PML RARA t15 17q22q12 Gene Rearrangement Quantitative MRD Monitor Test
Introduction to the Test
The PML RARA t15 17q22q12 Gene Rearrangement Quantitative MRD Monitor Test is a specialized diagnostic tool essential for monitoring minimal residual disease (MRD) in patients diagnosed with acute promyelocytic leukemia (APL). This test employs advanced Real Time PCR technology to detect specific genetic rearrangements, which are critical in assessing the effectiveness of treatment and guiding further therapeutic decisions.
What the Test Measures
This test specifically measures the presence of the PML-RARA fusion gene, which is a hallmark of APL. By quantifying the level of this gene in the patient’s blood or bone marrow, healthcare providers can determine the extent of disease presence, even after treatment, thus allowing for timely interventions.
Who Should Consider This Test?
Patients diagnosed with acute promyelocytic leukemia (APL) should consider this test, especially those who have undergone treatment and require monitoring for disease recurrence. Symptoms that may prompt testing include:
- Unexplained fatigue
- Fever
- Frequent infections
- Easy bruising or bleeding
Additionally, individuals with a family history of leukemia or other risk factors may also be advised to undergo this test.
Benefits of Taking the Test
- Provides critical information on the effectiveness of ongoing treatment.
- Helps in the early detection of disease recurrence.
- Guides healthcare providers in making informed decisions regarding further treatment options.
- Enhances patient management and follow-up care.
Understanding Your Results
Results from the PML RARA t15 17q22q12 Gene Rearrangement Quantitative MRD Monitor Test will indicate the level of the PML-RARA fusion gene present in the sample. A decrease in the levels post-treatment is generally a positive sign, indicating effective disease management. However, any increase may necessitate further investigation or changes in treatment strategy.
Test Pricing
| Test Name | Price (KSh) |
|---|---|
| PML RARA t15 17q22q12 Gene Rearrangement Quantitative MRD Monitor Test | Discount Price: 12168 KSh |
| Regular Price: 13520 KSh |
Sample Collection and Instructions
Sample type required for this test is 5 mL (3 mL min.) of whole blood or bone marrow collected in a Lavender Top (EDTA) tube. It is crucial to ship the sample refrigerated and to avoid freezing. Additionally, a duly filled MRD Requisition form (Form 22) with historical data is mandatory for processing.
Branches and Booking
We have branches across all major cities in Kenya, including Nairobi, Mombasa, Kisumu, and Nakuru, ensuring easy access for our patients. For your convenience, we also offer home sample collection services. To book the PML RARA t15 17q22q12 Gene Rearrangement Quantitative MRD Monitor Test, please call or WhatsApp us at +254711564616.
